MBX-8025

· Gilead Sciences

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MBX-8025, covering 2015-06-12 to 2016-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Effects of MBX-8025 in Patients With HoFH [Phase 2]